Purpose of the study: to evaluate the impact of complex treatment and medical rehabilitation of after stroke patients based on development and clinical validation of a new WO:EX therapy method.
Inclusion criteria: 1) clinically validated diagnosis of cerebral infarction with hemiparesis; 2) age over 40 years; 3) stroke, corresponded by 7-15 points of The National Institutes of Health Stroke Scale; 4) the time elapsed from the moment of the brain accident - from 3 weeks to 6 months; 5) willingness of the patient to participate in the study.
Exclusion criteria: 1) clinically confirmed COVID-19; 2) cognitive impairments; 3) 7 days hospitalization or less; 4) moderately severe pain; 5) any negative complaints that arise during the course of the study; 6) refusal to participate in the study.
Study involved 57 (n=57) after stroke patients: 30 (53%) patients included into main group (undertaken WO:EX THERAPY in combination with standard treatment), and 27 (47%) patients into control group (with standard treatment)
Before (index 1) and after (index 2) treatment, all participants were evaluated by:
Curve of operational characteristics (ROC) of the variable ΔSSS in assessing the effectiveness of the therapy